Abstract: An industrial vehicle includes a vehicle body, an electric component and a counterweight. The electric component of the industrial vehicle is mounted on the vehicle body. The counterweight is mounted on the vehicle body at the rear end and rearward of the electric component. The counterweight has a recess formed extending forwardly of the vehicle body from the rear end surface of the counterweight and an air passage formed extending upwardly of the vehicle body toward the electric component from an opening formed at the top surface of the recess. The recess has a closed end at a position forward of the opening of the air passage.

Abstract: A fine treatment agent according to the present invention is a fine treatment agent for the fine treatment of a multilayer film, including a tungsten film and a silicon oxide film comprising at least one from among hydrogen fluoride, nitric acid, ammonium fluoride and ammonium chloride. Thus, a fine treatment agent which makes fine treatment on a multilayer film, including a tungsten film and a silicon oxide film, possible by controlling the etching rate and a fine treatment method using the same can be provided.

Abstract: According to one aspect of the invention, there is provided a mobile apparatus including: a sensor configured to detect acceleration applied to the mobile apparatus and to generate a detection signal; a memory configured to record count data based on the detection signal, the count data associated with movement of the mobile apparatus; a counting module configured to count the number of user's steps based on the count data; a sound module configured to sound; and a counting control module configured to control the counting module to stop counting of the number of user's steps when the sound module starts sounding.

Abstract: A novel non-peptide CXCR4 antagonist has a low molecular-weight and uses various aromatic compounds, each containing a dipicolylamine-zinc complex. This CXCR4 antagonist finds use, e.g., as an anti-HIV agent, a metastasis inhibitor for a malignant tumor, and a chronic rheumatoid arthritis treatment and/or prevention agent.

Abstract: A fine treatment agent according to the present invention is a fine treatment agent for the fine treatment of a multilayer film, including a tungsten film and a silicon oxide film comprising at least one from among hydrogen fluoride, nitric acid, ammonium fluoride and ammonium chloride. Thus, a fine treatment agent which makes fine treatment on a multilayer film, including a tungsten film and a silicon oxide film, possible by controlling the etching rate and a fine treatment method using the same can be provided.

Abstract: Substituted pyrazole compounds of the formula (1). The compounds are synthesized from a pyrazole derivative and a haloalkyleneoxime ester derivative, and have excellent herbicidal effects.

Abstract: An information center generates packets of route guidance information, each corresponding to a prescribed road length of a recommended route. The information center may generate major guide point information and guidance information and transmit both to a vehicular apparatus. The vehicular apparatus provides guidance only for major guide points based on the received major guide point information if it cannot receive the guidance information. According to another aspect of the invention, if the end of a route segment which was the subject of the preceding route guidance information is on an expressway or toll road, guidance information for a preliminary route from that end to an escape position ahead on the expressway or toll road is first transmitted and then information for a remaining route, that is a segment of the recommended route having the prescribed road length minus the preliminary route, is then transmitted.

Abstract: Substituted pyrazole compounds of the formula (1). The compounds are synthesized from a pyrazole derivative and a haloalkyleneoxime ester derivative, and have excellent herbicidal effects. Herbicide compositions containing the substituted pyrazole derivatives or hydrazide derivatives thereof as active ingredients possess wide herbicidal spectra, work sufficiently in small dosages, and are sufficiently safe for certain important crops.

Abstract: An information center generates packets of route guidance information, each corresponding to a prescribed road length of a recommended route. The information center may generate major guide point information and guidance information and transmit both to a vehicular apparatus. The vehicular apparatus provides guidance only for major guide points based on the received major guide point information if it cannot receive the guidance information. According to another aspect of the invention, if the end of a route segment which was the subject of the preceding route guidance information is on an expressway or toll road, guidance information for a preliminary route from that end to an escape position ahead on the expressway or toll road is first transmitted and then information for a remaining route, that is a segment of the recommended route having the prescribed road length minus the preliminary route, is then transmitted.

Abstract: A vehicle control device controls an automatic transmission by utilizing road information stored in a navigation system unit. In response to the road information stored in a data memory, the upper-limit of a shiftable transmission speed range is determined, thereby allowing shift-change only within the restricted transmission range. The actual down-shift is carried out after confirming a decelerating operation by the driver, such as release of the accelerator pedal, thereby providing favorable transmission control in conformity with the driver's intention.

Abstract: An apparatus for controlling an automatic transmission of an automobile and a method therefor utilize a route guidance system. The apparatus includes a memory which stores road information, a detector for detecting a specific position which is located on a planned driving route from the road information stored in the memory; a position detector for detecting the present position of the automobile; a speed detector for detecting the speed V of the automobile; a sensor for detecting an opening degree .theta. of a throttle of the automobile; a computer for computing a distance "d" between the detected automobile position and the detected specific position; a driving operation detector for detecting an operation by the driver of the automobile; a first gear ratio selecting device for selecting a first gear ratio for the automatic transmission based on the detected speed V and the detected throttle opening degree .theta.

Abstract: A vehicle, which is either an electric vehicle or a hybrid vehicle, capable of achieving low-pollution emissions and saving energy by maximizing use of the capacity of the battery. A navigation ECU receives input identifying a starting location where the battery is charged, a stopover location, and a destination where battery recharging is planned, and calculates travel distances from the starting location to the stopover location and to the destination based on geographic data for the starting location, the stopover location and the destination, and schedules electric power consumption corresponding to distance travelled, based on the respective calculated distances, to assign a battery residual capacity usage value for each leg of the trip. A vehicle ECU supplies electric power from the battery to the motor in accordance with that schedule.

Abstract: A hybrid vehicle has an engine and a generator/motor connected through a planetary gear unit to an output shaft and the output of the engine is distributed between the generator and the output shaft. The vehicle is smoothly started by a driving motor. When vehicle speed V reaches an engine starting speed V*, the speed of generator/motor is changed to cause the engine to rotate, the engine is ignited and driving continues with the output torque produced by the engine supplemented by the driving motor. The hybrid vehicle allows for a smooth start and improved driving comfort even if an engine interruption scheme for halting the engine is employed, for example, halting the vehicle while waiting for a traffic signal to change.

Abstract: The invention relates to compositions and methods for inhibiting infection or suppressing growth of human immunodeficiency virus. The composition comprises, as an effective component, an iron-binding protein (e.g., lactoferrin, transferrin, ovotransferrin), a chemically modified compound of the iron-binding protein, or a hydrolyzed compound of the iron-binding protein. The effective components are safe and can be easily prepared from inexpensive raw materials. The composition can be orally administered, injected or applied to the skin, eye, ear, nose or used as a preparation for vagina affusion, mouth washing or suppositories, and can effectively inhibit infection or suppress growth of human immunodeficiency virus.

Abstract: The present invention provides a reverse transcriptase inhibitor and an antiviral agent comprising at least one member selected from the group consisting of sulfated tyrosines and physiologically acceptable salts thereof as an effective component; and exhibiting less toxicity and a remarkable inhibitory effect against a reverse transcriptase existing in viruses as well as a remarkable anti-AIDS viral activity.

Abstract: This invention relates to inhibitors against viral infection and proliferation composed of peptides shown by below mentioned amino acid sequence (1) or (2). ##STR1## The inhibitors against viral infection and proliferation of the present invention can suppress the infection and proliferation of influenza virus or cytomegalo virus, and are useful for the prevention and treatment of diseases caused by these viruses.

Abstract: A beta-1,3-glucan of sulfated curdlan having a sulfur content of 12.4 to 17% and an average molecular weight of 27,000 to 330,000 daltons. Sulfate curdlan exhibits strong HIV inhibitory activity with little anticoagulant activity and little toxicity.

Abstract: Oligosaccharide aromatic glycoside sulfates and physiologically acceptable salts thereof, are disclosed. Further, antiviral agents having these sulfate compounds as the active components, and particularly an antiviral agent, wherein the virus is one which causes AIDS (Acquired Immune Deficiency Syndrome), are disclosed. The active components or the glycoside sulfates, and the salts thereof, are characterized by an oligosaccharide aromatic glycoside sulfate in which the hydrogen of the position-1 hydroxyl group of the terminal sugar of an oligosaccharide is substituted with a specified formula having an alkyl group consisting of 1 to 18 carbons, an oxygen or no oxygen, and an allylene group. The number of constituent monosaccharides in the oligosaccharide portion is preferably within a range of 2 to 20. Further, 10% or more of the remaining hydroxyl groups of the sugar subunits are subjected to sulfated esterification.

Abstract: A sulfated oligoglycoside acylate comprising monosaccharides of a single or two kinds as the constituents, wherein the hydrogen in the hydroxyl group at the 1-position of a reducing end sugar of the oligosaccharide formed via the glycoside bond of these monosaccharides has been substituted with an aglycon selected from a group consisting of alkyl groups, aromatic alkyl groups, aromatic alkoxy groups and tocopheryl groups; from 12 to 80% of the residual hydroxyl groups have been acylated with an acyl group selected from a group consisting of aliphatic acyl groups and aromatic acyl groups; and 88 to 20% thereof have been sulfated; or a physiologically acceptable salt thereof provided that compounds wherein the aglycon is an alkyl group and the acyl group is an aliphatic acyl group are excluded is disclosed. Further, an antiviral agent, which exerts a long-lasting antiviral action particularly on HIV, containing said compound as an active ingredient is disclosed.

Abstract: The present invention relates to novel tocopheryl oligosaccharides, acylated tocopheryl oligosaccharides, sulfated tocopheryl oligosaccharides, and antiviral agents including the sulfated tocopheryl oligosaccharides as active ingredients. In the tocopheryl oligosaccharide, the hydrogen atom of the hydroxy group at the 1-position in the terminal sugar moiety of an oligosaccharide which consists of 3.about.20 of identical or different repeating monosaccharide units selected from the group consisting of glucose, galactose, mannose, talose, idose, altrose, allose, glucose, xylose, arabinose, rhamnose, fucose, and fructose, which are glycoside-linked, is substituted by a tocopherol group. In the acylated tocopheryl oligosaccharides, each of any hydroxy group of the sugar moiety, other than the hydroxy group at the 1-position in the terminal sugar moiety of the oligosaccharide described above, is protected by an acyl group.